Result Number | Material Type | Add to My Shelf Action | Record Details and Options |
---|---|---|---|
1 |
Material Type: Standards
|
Epidermal radiotherapy using rhenium-188 paste for non-melanoma skin cancerNICE Guidance, 2024Copyrights: © NICE 2024 All rights reserved. Subject to Notice of rightsDigital Resources/Online E-Resources |
|
2 |
Material Type: Standards
|
Belumosudil for treating chronic graft-versus-host disease after 2 or more systemic treatments in people 12 years and overNICE Guidance, 2024Copyrights: © NICE 2024 All rights reserved. Subject to Notice of rightsDigital Resources/Online E-Resources |
|
3 |
Material Type: Standards
|
Artificial intelligence (AI)-derived software to help clinical decision making in strokeNICE Guidance, 2024Copyrights: © NICE 2024 All rights reserved. Subject to Notice of rightsDigital Resources/Online E-Resources |
|
4 |
Material Type: Standards
|
Lutetium-177 vipivotide tetraxetan for treating PSMA-positive hormone-relapsed metastatic prostate cancer after 2 or more treatmentsNICE Guidance, 2023Copyrights: © NICE 2023 All rights reserved. Subject to Notice of rightsDigital Resources/Online E-Resources |
|
5 |
Material Type: Standards
|
Vaginal transluminal endoscopic hysterectomy and adnexal surgery for benign gynaecological conditionsNICE Guidance, 2023Copyrights: © NICE 2023 All rights reserved. Subject to Notice of rightsDigital Resources/Online E-Resources |
|
6 |
Material Type: Standards
|
Glofitamab for treating relapsed or refractory diffuse large B-cell lymphoma after 2 or more systemic treatmentsNICE Guidance, 2023Copyrights: © NICE 2023 All rights reserved. Subject to Notice of rightsDigital Resources/Online E-Resources |
|
7 |
Material Type: Standards
|
Artificial intelligence technologies to aid contouring for radiotherapy treatment planning: early value assessmentNICE Guidance, 2023Copyrights: © NICE 2023 All rights reserved. Subject to Notice of rightsDigital Resources/Online E-Resources |
|
8 |
Material Type: Standards
|
Afamelanotide for treating erythropoietic protoporphyriaNICE Guidance, 2023Copyrights: © NICE 2023 All rights reserved. Subject to Notice of rightsDigital Resources/Online E-Resources |
|
9 |
Material Type: Standards
|
Axicabtagene ciloleucel for treating relapsed or refractory follicular lymphomaNICE Guidance, 2023Copyrights: © NICE 2023 All rights reserved. Subject to Notice of rightsDigital Resources/Online E-Resources |
|
10 |
Material Type: Standards
|
Axicabtagene ciloleucel for treating diffuse large B-cell lymphoma and primary mediastinal large B-cell lymphoma after 2 or more systemic therapiesNICE Guidance, 2023Copyrights: © NICE 2023 All rights reserved. Subject to Notice of rightsDigital Resources/Online E-Resources |
|
11 |
Material Type: Standards
|
Maribavir for treating refractory cytomegalovirus infection after transplantNICE Guidance, 2023Copyrights: © NICE 2023 All rights reserved. Subject to Notice of rightsDigital Resources/Online E-Resources |
|
12 |
Material Type: Standards
|
Mobocertinib for treating EGFR exon 20 insertion mutation-positive advanced non-small-cell lung cancer after platinum-based chemotherapyNICE Guidance, 2023Copyrights: © NICE 2023 All rights reserved. Subject to Notice of rightsDigital Resources/Online E-Resources |
|
13 |
Material Type: Standards
|
Amivantamab for treating EGFR exon 20 insertion mutation-positive advanced non-small-cell lung cancer after platinum-based chemotherapyNICE Guidance, 2022Copyrights: © NICE 2022 All rights reserved. Subject to Notice of rightsDigital Resources/Online E-Resources |
|
14 |
Material Type: Standards
|
Memokath 051 Ureter stent for ureteric obstructionNICE Guidance, 2022Copyrights: © NICE 2022 All rights reserved. Subject to Notice of rightsDigital Resources/Online E-Resources |
|
15 |
Material Type: Standards
|
Fostamatinib for treating refractory chronic immune thrombocytopeniaNICE Guidance, 2022Copyrights: © NICE 2022 All rights reserved. Subject to Notice of rightsDigital Resources/Online E-Resources |
|
16 |
Material Type: Standards
|
PLGF-based testing to help diagnose suspected preterm pre-eclampsiaNICE Guidance, 2022Copyrights: © NICE 2022 All rights reserved. Subject to Notice of rightsDigital Resources/Online E-Resources |
|
17 |
Material Type: Standards
|
Roxadustat for treating symptomatic anaemia in chronic kidney diseaseNICE Guidance, 2022Copyrights: © NICE 2022 All rights reserved. Subject to Notice of rightsDigital Resources/Online E-Resources |
|
18 |
Material Type: Standards
|
Icosapent ethyl with statin therapy for reducing the risk of cardiovascular events in people with raised triglyceridesNICE Guidance, 2022Copyrights: © NICE 2022 All rights reserved. Subject to Notice of rightsDigital Resources/Online E-Resources |
|
19 |
Material Type: Standards
|
Liposuction for chronic lipoedemaNICE Guidance, 2022Copyrights: © NICE 2022 All rights reserved. Subject to Notice of rightsDigital Resources/Online E-Resources |
|
20 |
Material Type: Standards
|
Sedaconda ACD-S for sedation with volatile anaesthetics in intensive careNICE Guidance, 2022Copyrights: © NICE 2022 All rights reserved. Subject to Notice of rightsDigital Resources/Online E-Resources |